Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models

Journal of Microbiology

Volumn 49, Issue 6, 2011, Pages 994-999

  Tiwari, Birendra R ^a   Kim, Shukho ^a   Rahman, Marzia ^a   Kim, Jungmin ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

bacteriophage therapy; neutropenic mouse; Pseudomonas aeruginosa

Indexed keywords

ANIMAL; ARTICLE; BACTERIOLYSIS; BIOLOGICAL THERAPY; DISEASE MODEL; EVALUATION; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METHODOLOGY; MICROBIOLOGY; MOUSE; NEUTROPENIA; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PSEUDOMONAS PHAGE; VIROLOGY;

ANIMALS; BACTERIOLYSIS; BIOLOGICAL THERAPY; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED ICR; NEUTROPENIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES;

BACTERIA (MICROORGANISMS); MUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84555206971     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-011-1512-4     Document Type: Article

References (36)

1. Ahmad, S. I. 2002. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Med. Hypotheses 58, 327-331.
2. Akinyemi, K. O., W. Philipp, W. Beyer, and R. Bohm. 2010. Application of phage typing and pulsed-field gel electrophoresis to analyse Salmonella enterica isolates from a suspected outbreak in Lagos, Nigeria. J. Infect. Dev. Ctries. 4, 828-833.
3. Biswas, B. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70, 204-210.
4. Borysowski, J. and A. Gorski. 2008. Is phage therapy acceptable in the immunocompromised host? Int. J. Infect. Dis. 12, 466-471.
5. Bullwinkle, T. J. and G. B. Koudelka. 2011. The lysis-lysogeny decision of bacteriophage 933W: a 933W repressor-mediated long-distance loop has no role in regulating 933W PRM activity. J. Bacteriol. 193, 3313-3323.
6. Capparelli, R., N. Nocerino, M. Iannaccone, D. Ercolini, M. Parlato, M. Chiara, and D. Iannelli. 2010. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J. Infect. Dis. 201, 52-61.
7. Capparelli, R., M. Parlato, G. Borriello, P. Salvatore, and D. Iannelli. 2007. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51, 2765-2773.
8. Carlton, R. M. 1999. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz). 47, 267-274.
9. Comeau, A. M., F. Tetart, S. N. Trojet, M. F. Prere, and H. M. Krisch. 2007. Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One. 2, e799.
10. Ferrante, A. and Y. H. Thong. 1978. A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J. Immunol. Methods 24, 389-393.
11. Fu, W., T. Forster, O. Mayer, J. J. Curtin, S. M. Lehman, and R. M. Donlan. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54, 397-404.
12. Goode, D., V. M. Allen, and P. A. Barrow. 2003. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl. Environ. Microbiol. 69, 5032-5036.
13. Heo, Y. J., Y. R. Lee, H. H. Jung, J. Lee, G. Ko, and Y. H. Cho. 2009. Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster. Antimicrob. Agents Chemother. 53, 2469-2474.
14. Housby, J. N. and N. H. Mann. 2009. Phage therapy. Drug Discov. Today 14, 536-540.
15. Hughes, W. T., D. Armstrong, G. P. Bodey, E. J. Bow, A. E. Brown, T. Calandra, R. Feld, P. A. Pizzo, K. V. Rolston, J. L. Shenep, and L. S. Young. 2002. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34, 730-751.
16. Kalmar, J. R., R. R. Arnold, M. L. Warbington, and M. K. Gardner. 1988. Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J. Immunol. Methods 110, 275-281.
17. Kocharunchitt, C., T. Ross, and D. L. McNeil. 2009. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int. J. Food Microbiol. 128, 453-459.
18. Kumari, S., K. Harjai, and S. Chhibber. 2009. Bacteriophage treatment of burn wound infection caused by Pseudomonas aeruginosa PAO in BALB/c Mice. Am. J. Biomed. Sci. 385-394.
19. Kutateladze, M. and R. Adamia. 2008. Phage therapy experience at the Eliava Institute. Med. Mal. Infect. 38, 426-430.
20. Levin, B. R. and J. J. Bull. 2004. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2, 166-173.
21. McVay, C. S., M. Velasquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51, 1934-1938.
22. Merabishvili, M., J. P. Pirnay, G. Verbeken, N. Chanishvili, M. Tediashvili, N. Lashkhi, T. Glonti, V. Krylov, J. Mast, L. van Parys, and et al. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One. 4, e4944.
23. O'Flynn, G., R. P. Ross, G. F. Fitzgerald, and A. Coffey. 2004. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7. Appl. Environ. Microbiol. 70, 3417-3424.
24. Preisner, O., R. Guiomar, J. Machado, J. C. Menezes, and J. A. Lopes. 2010. Application of Fourier transform infrared spectroscopy and chemometrics for differentiation of Salmonella enterica serovar Enteritidis phage types. Appl. Environ. Microbiol. 76, 3538-3544.
25. Repine, J. E., C. C. Clawson, and F. C. Goetz. 1980. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J. Infect. Dis. 142, 869-875.
26. Reynolds, A., C. R. Moffatt, A. Dyda, R. L. Hundy, A. L. Kaye, R. Krsteski, S. Rockliff, R. Kampen, P. M. Kelly, and E. D. O'Brien. 2010. An outbreak of gastroenteritis due to Salmonella Typhimurium phage type 170 associated with consumption of a dessert containing raw egg. Commun. Dis. Intell. 34, 329-333.
27. Satapathy, A. K. and C. C. Richardson. 2011. The glutamate switch of bacteriophage T7 DNA helicase: role in coupling NTP and DNA binding to NTP hydrolysis. J. Biol. Chem. 286, 23113-23120.
28. Sillankorva, S., E. Pleteneva, O. Shaburova, S. Santos, C. Carvalho, J. Azeredo, and V. Krylov. 2010. Salmonella Enteritidis bacteriophage candidates for phage therapy of poultry. J. Appl. Microbiol. 108, 1175-1186.
29. Uchiyama, J., Y. Maeda, I. Takemura, R. Chess-Williams, H. Wakiguchi, and S. Matsuzaki. 2009. Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice. Microbiol. Immunol. 53, 301-304.
30. Usher, L. R., R. A. Lawson, I. Geary, C. J. Taylor, C. D. Bingle, G. W. Taylor, and M. K. Whyte. 2002. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J. Immunol. 168, 1861-1868.
31. Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, E. Reed, L. Ding, J. Gong, Q. Q. Li, and J. Hu. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med. 17, 309-317.
32. Waseh, S., P. Hanifi-Moghaddam, R. Coleman, M. Masotti, S. Ryan, M. Foss, R. MacKenzie, M. Henry, C. M. Szymanski, and J. Tanha. 2010. Orally administered P22 phage tailspike protein reduces Salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One. 5, e13904.
33. Watanabe, R., T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y. Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, and K. Yamaguchi. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51, 446-452.
34. Weber-Dabrowska, B., M. Zimecki, M. Mulczyk, and A. Gorski. 2002. Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunol. Med. Microbiol. 34, 135-138.
35. Whelan, J., H. Noel, I. Friesema, A. Hofhuis, C. M. de Jager, M. Heck, A. Heuvelink, and W. van Pelt. 2010. National outbreak of Salmonella Typhimurium (Dutch) phage-type 132 in the Netherlands, October to December 2009. Euro. Surveill. 15.
36. Zilberberg M. D., J. Chen, S. H. Mody, A. M. Ramsey, and A. F. Shorr. 2010. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm. Med. 10, 45.